These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections.
    Author: Steenbergen JN, Alder J, Thorne GM, Tally FP.
    Journal: J Antimicrob Chemother; 2005 Mar; 55(3):283-8. PubMed ID: 15705644.
    Abstract:
    Infections caused by drug-resistant pathogens are on the rise. Daptomycin, a cyclic lipopeptide with activity against most Gram-positive pathogens, including vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus, is a newly US-FDA approved antimicrobial for complicated skin and skin structure infections (cSSSI). Daptomycin has a unique mechanism of action that results in destruction of the membrane potential. The rapid bactericidal activity of daptomycin makes it an attractive antibiotic for serious Gram-positive infections.
    [Abstract] [Full Text] [Related] [New Search]